| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Omega Therapeutics, Inc. | Director | Common Stock | 53,082 | $424,656 | $8.00 | 03 Aug 2021 | Direct |
| Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19,852 | 29 Jul 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OACC | Oaktree Acquisition Corp. III Life Sciences | 17 Oct 2025 | 0 | $0 | 3 | Director | 22 Oct 2025, 16:30 |
| OMGA | Omega Therapeutics, Inc. | 03 Aug 2021 | 1 | +$902,394 | 4 | Director | 03 Aug 2021, 17:15 |
| OMGA | Omega Therapeutics, Inc. | 29 Jul 2021 | 1 | $0 | 4 | Director | 30 Jul 2021, 17:05 |
| OMGA | Omega Therapeutics, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 21:02 |